NYU’s ‘Dean of Valuation’: Elon Musk’s SpaceX Isn’t Worth $1.77 Trillion

In this week's episode of WSJ’s Take On the Week, co-hosts Miriam Gottfried and Telis Demos break down the unconventional lead-up to the SpaceX IPO. They examine the rocket maker's choice to propose a single price of $135 a share this past week, rather than a range, which set the valuation at around $1.77 trillion. The hosts also discuss the number of shares being offered to retail investors and the broader IPO boom—including Anthropic and OpenAI—that is poised to impact passive index investors.

After the break, they are joined by NYU Stern School of Business professor Aswath Damodaran, widely known as the "Dean of Valuation" or the "Valuation Guru." Damodaran dissects SpaceX's estimated more than $28 trillion total addressable market, calling the around $26 trillion portion tied to AI more of a "wish than an expectation." He talks about the risks of investing in a founder-controlled company like SpaceX, where Elon Musk retains the majority of the voting rights due to its share structure. He also explains why momentum for the company’s stock could matter more than valuation.

This is WSJ’s Take On the Week where co-hosts Telis Demos, Heard on the Street’s banking and money columnist, and Miriam Gottfried, WSJ’s investing and wealth management reporter, cut through the noise and dive into markets, the economy and finance—the big trades, key players and business news ahead.

Have an idea for a future guest or episode? How can we better help you take on the week? We’d love to hear from you. Email the show at takeontheweek@wsj.com.

To watch the video version of this episode, visit our WSJ Podcasts YouTube channel or the video page of WSJ.com

Avsnitt(134)

Will Real Estate Protect Your Portfolio if the AI Bubble Bursts?

In this week's episode of WSJ’s Take On the Week, co-hosts Telis Demos and Miriam Gottfried break down the conversation around AI safety and development, and how markets have reacted. Plus, OpenAI is ...

20 Sep 35min

A Breakthrough Cancer Vaccine Fueled a Biotech Rally. Can It Last?

Despite a rough past week for the healthcare sector, pharmaceuticals and biotech stocks have outperformed the S&P 500 this year. Investors have gotten excited over cancer treatment breakthroughs for M...

13 Sep 30min

How AI Speculation Is Fueling the Small-Cap Stock Rally

On this week’s episode of WSJ’s Take On the Week, host Miriam Gottfried and guest host Aaron Back, editor of WSJ’s Heard on the Street, preview the upcoming employment and inflation releases in advanc...

30 Aug 29min

What Fed Chair Kevin Warsh’s Jackson Hole Debut Means for Nervous Markets

In this week's episode of WSJ’s Take On the Week, co-hosts Miriam Gottfried and Telis Demos preview the upcoming Jackson Hole Economic Policy Symposium—one of the longest-standing central banking conf...

23 Aug 32min

How to Make Inflation Work for Your Portfolio

In this week's episode of WSJ’s Take On the Week, we dig into Treasury Inflation Protected Securities, or TIPS! Our co-hosts Miriam Gottfried and Telis Demos are joined by Jill Cetina, finance profess...

16 Aug 35min

How AI Spending Is Fueling the Economy Overall

In this week's episode of WSJ’s Take On the Week, co-hosts Miriam Gottfried and Telis Demos dig into the shifting sentiment away from AI stocks and the pivot into consumer sectors. Are we heading into...

9 Aug 35min

Why Oil Prices Could Hit a Breaking Point by Year End

In this episode of WSJ’s Take On the Week, co-host Telis Demos is joined by guest co-host and Wall Street Journal reporter David Uberti to break down the Federal Reserve’s latest moves, and what oil’s...

2 Aug 34min

The Buried $150B Bet Inside the Top 20 U.S. Stocks

In this week's episode of WSJ’s Take On the Week, host Telis Demos and guest host Spencer Jakab, the Wall Street Journal’s investing columnist and writer of the Markets A.M. newsletter, are joined by ...

26 Juli 32min